Premium
Tumor necrosis factor‐α regulates in vivo nitric oxide synthesis and induces liver injury during endotoxemia
Author(s) -
Harbrecht Brian G.,
Silvio Mauricio Di,
Demetris A. J.,
Simmons Richard L.,
Billiar Timothy R.
Publication year - 1994
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.1840200439
Subject(s) - nitric oxide , tumor necrosis factor alpha , nitric oxide synthase , in vivo , lipopolysaccharide , medicine , nitrite , endocrinology , chemistry , necrosis , biology , nitrate , microbiology and biotechnology , organic chemistry
Tumor necrosis factor‐alpha is a principal mediator of the pathophysiological effects of endotoxemia and endotoxin shock. Tumor necrosis factor‐α also contributes to the stimulation of nitric oxide synthesis by the induction of the enzyme nitric oxide synthase in a variety of tissues. Although the importance of tumor necrosis factor‐α in the induction of nitric oxide synthase activity in vitro is well known, its role in in vivo nitric oxide synthesis has not been convincingly established. We were interested in determining whether tumor necrosis factor‐α plays a significant role in the in vivo induction of nitric oxide synthesis. In Corynebacterium parvum —primed mice, lipopolysaccharide injection resulted in elevated serum tumor necrosis factor‐α levels early and increased hepatic enzyme release (641 ± 80 IU AST/L 22.7 ± 1.9 IU ornithine carbamoyltransferase per liter) and plasma nitrite and nitrate (804 ± 84 μmol/L) 5 hr after lipopolysaccharide injection. Polyclonal rabbit anti‐mouse anti—tumor necrosis factor‐α reduced in vivo tumor necrosis factor‐α levels (1 hr, 7,332 ± 1,492 U tumor necrosis factor‐α per milliliter) and reduced nitric oxide synthesis as measured by plasma nitrite and nitrate (352 ± 69 μmol/L). Polyclonal rabbit anti‐mouse anti—tumor necrosis factor‐α also reduced lipo‐polysaccharide‐induced hepatic enzyme release (428 ± 33 IU AST/L 16.0 ± 2.5 IU ornithine carbamoyltransferase per liter). N G ‐monomethyl‐L‐arginine, a competitive inhibitor of nitric oxide synthesis, also decreased plasma nitrite and nitrate (104 ± 9 μmol/L) but increased the lipopolysaccharide‐induced hepatic injury (797 ± 66 IU AST/L 33.1 ± 2.1 IU ornithine carbamoyltransferase per liter). These results show that tumor necrosis factor‐α not only acts as an in vivo signal for the induction of nitric oxide synthesis but also acts as a mediator of the lipopolysaccharide‐induced hepatic injury. The mechanism by which tumor necrosis factor‐α exerts its damaging effect on hepatic cells has not been determined but appears to be independent of its induction of nitric oxide synthesis. (Hepatology 1994;20:1055–1060).